Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A LOng-term Follow-up Master Protocol for Participants Who Received Cell or Gene Therapies in Other AstraZeneca StUdieS (LOCUS)

NCT06194461 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06194461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06194461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A LOng-term Follow-up Master Protocol for Participants Who Received Cell or Gene Therapies in Other AstraZeneca StUdieS (LOCUS)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Not yet recruiting
Start date
September 17, 2025
Completion date
November 29, 2041
Enrollment
64 (estimated)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, prostate cancer